INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Results

76,350 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
RD
Rico Robert DanielChief Accounting Officer
GLXYGalaxy Digital Inc.
Option exercise
M$107K
9,095 sh
Aug 6, 2026Aug 10, 2026
Page 676 of 1909
← PrevNext →
traded Aug 6, 2026
+4d
SEC Form 4

Evidence

12
MJ
Murtagh Nigel JChief Risk Officer
SCHWSCHWAB CHARLES CORP
Option exercise · 10b5-1 plan
M$1.16M
24.8K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

12
SG
Sotiros GeorgeVP - INFORMATION SYSTEMS
WEYSWEYCO GROUP INC
Tax withholding
F$97K
2,207 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

12
PH
Printer HoshiDirector
LTRXLANTRONIX INC
Gift
G—
34.6K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

12
LT
Lavin Michael T.President
CPSSCONSUMER PORTFOLIO SERVICES, INC.
Option exercise
M$113K
45.8K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

12
CE
Cactus WH Enterprises, LLC10% Owner
WHDCactus, Inc.
Other acquisition or disposition
J—
25.0K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$52K
250 sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$122K
578 sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$105K
506 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$109K
534 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$112K
521 sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$111K
546 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

11
BE
Bechelany Pierre EdwardGroup President
FLRFLUOR CORP
Open-market sale · 10b5-1 plan
SELL$276K
5,000 sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

11
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$397K
15.2K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

11
KA
King Ryan ADirector, Co-Founder
CHYMChime Financial, Inc.
Derivative conversion · 10b5-1 plan
C—
337.9K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

11
TA
Toy AndrewDirector, Chief Executive Officer
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$408K
87.8K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

11
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$543K
20.8K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$86K
400 sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

10
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Option exercise
M—
141.8K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

9
SG
Sotiros GeorgeVP - INFORMATION SYSTEMS
WEYSWEYCO GROUP INC
Option exercise
M$22K
780 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
CG
Combs Michael GCEO & President
CRVLCORVEL CORP
Grant or award
A—
1,500 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
RE
Regan Michael EdwardDirector
PFSPROVIDENT FINANCIAL SERVICES INC
Grant or award
A—
3,066 sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

9
CJ
Cui Jingrong JeanDirector, President and CEO, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
124.8K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
AS
Agrawal SundeepDirector
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
578.5K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
KB
Koutsouras BillDirector
GLXYGalaxy Digital Inc.
Grant or award
A—
7,866 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
SG
Sotiros GeorgeVP - INFORMATION SYSTEMS
WEYSWEYCO GROUP INC
Option exercise
M$29K
1,200 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
BM
Burkey Joanna M.Director
CRVLCORVEL CORP
Grant or award
A—
1,500 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
MW
McIntosh Greg WEVP, Chief Commercial Officer
IRMIRON MOUNTAIN INC
Option exercise · 10b5-1 plan
M$253K
6,839 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
RT
Rottinghaus Scott T.Chief Medical Officer
ENTAENANTA PHARMACEUTICALS INC
Tax withholding
F$20K
1,467 sh
Aug 8, 2026Aug 10, 2026
traded Aug 8, 2026
+2dSEC Form 4

Evidence

9
LY
Li YishanDirector, Executive Chairman, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
1.60M sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
LY
Li YishanDirector, Executive Chairman, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
1.60M sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
LY
Li YishanDirector, Executive Chairman, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Grant or award
A—
112.7K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
SS
Stellato StevenSee Remarks
KNTKKinetik Holdings Inc.
Grant or award
A—
10.8K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

9
TS
Tomsic StevenChief Financial Officer
FOXFox Corp
Grant or award
A—
40.2K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

9
HR
Holmes Joseph R.VP & Chief Accounting Officer
TMOTHERMO FISHER SCIENTIFIC INC.
Option exercise
M—
420 sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

9
CJ
Cui Jingrong JeanDirector, President and CEO, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
1.60M sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
CJ
Cui Jingrong JeanDirector, President and CEO, 10% Owner
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
113.4K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

9
AS
Agrawal SundeepDirector
BLSMBlossomHill Therapeutics, Inc.
Grant or award
A—
23.9K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
RB
Rayhill BrianDirector
CPSSCONSUMER PORTFOLIO SERVICES, INC.
Option exercise
M—
30.0K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

9
DD
Daffey Michael DDirector
GLXYGalaxy Digital Inc.
Grant or award
A—
7,866 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence